Quick Answer
Zenas BioPharma, Inc. reported Total Revenue of $10.00 million for the year ending 2025.
- Zenas BioPharma, Inc. showed an increase of +0.0% in Total Revenue from 2025 to 2025.
- This data is from Zenas BioPharma, Inc.'s annual report (Form 10-K), filed with the SEC on March 16, 2026.
- XBRL data for this metric is available from 2023 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2023: $50.00 million | Q3 2023: $50.00 million | Q2 2024: $0.00 | Q3 2024: $0.00 | Q1 2025: $10.00 million | Q1 2025: $10.00 million | Q2 2025: $0.00 | Q3 2025: $0.00.
- Over the full 6 years of available data (2023 to 2025), Zenas BioPharma, Inc.'s Total Revenue has declined by 80.0%.
- Historical annual values: Fiscal year 2025: $10.00 million | Fiscal year 2025: $10.00 million | Fiscal year 2024: $5.00 million | Fiscal year 2024: $5.00 million | Fiscal year 2023: $50.00 million | Fiscal year 2023: $50.00 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: